• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌幸存者存在长期的、残留的全身免疫改变。

Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations.

作者信息

Balázs Katalin, Kocsis Zsuzsa S, Ágoston Péter, Jorgo Kliton, Gesztesi László, Farkas Gyöngyi, Székely Gábor, Takácsi-Nagy Zoltán, Polgár Csaba, Sáfrány Géza, Jurányi Zsolt, Lumniczky Katalin

机构信息

National Public Health Center, Unit of Radiation Medicine, Department of Radiobiology and Radiohygiene, 1221 Budapest, Hungary.

Doctoral School of Pathological Sciences, Semmelweis University, 1085 Budapest, Hungary.

出版信息

Cancers (Basel). 2022 Jun 22;14(13):3058. doi: 10.3390/cancers14133058.

DOI:10.3390/cancers14133058
PMID:35804830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9264868/
Abstract

BACKGROUND

The development of cancer and anti-tumor therapies can lead to systemic immune alterations but little is known about how long immune dysfunction persists in cancer survivors.

METHODS

We followed changes in the cellular immune parameters of prostate cancer patients with good prognostic criteria treated with low dose rate brachytherapy before and up to 3 years after the initiation of therapy.

RESULTS

Patients before therapy had a reduced CD4+ T cell pool and increased regulatory T cell fraction and these alterations persisted or got amplified during the 36-month follow-up. A significant decrease in the total NK cell number and a redistribution of the circulating NK cells in favor of a less functional anergic subpopulation was seen in patients before therapy but tumor regression led to the regeneration of the NK cell pool and functional integrity. The fraction of lymphoid DCs was increased in patients both before therapy and throughout the whole follow-up. Increased PDGF-AA, BB, CCL5 and CXCL5 levels were measured in patients before treatment but protein levels rapidly normalized.

CONCLUSIONS

while NK cell dysfunction recovered, long-term, residual alterations persisted in the adaptive and partly in the innate immune system.

摘要

背景

癌症的发展和抗肿瘤治疗可导致全身免疫改变,但对于癌症幸存者免疫功能障碍持续多长时间知之甚少。

方法

我们跟踪了符合良好预后标准的前列腺癌患者在低剂量率近距离放射治疗开始前及治疗后长达3年的细胞免疫参数变化。

结果

治疗前患者的CD4+T细胞池减少,调节性T细胞比例增加,这些改变在36个月的随访期间持续存在或加剧。治疗前患者的总自然杀伤(NK)细胞数量显著减少,循环NK细胞重新分布,有利于功能较弱的无反应亚群,但肿瘤消退导致NK细胞池再生和功能完整性恢复。治疗前及整个随访期间患者的淋巴树突状细胞比例均增加。治疗前患者的血小板衍生生长因子(PDGF)-AA、BB、趋化因子配体5(CCL5)和趋化因子CXCL5水平升高,但蛋白水平迅速恢复正常。

结论

虽然NK细胞功能障碍得以恢复,但适应性免疫系统及部分先天性免疫系统中长期残留的改变依然存在。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/69b4c00212b3/cancers-14-03058-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/2bc690d2ce58/cancers-14-03058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/1d356a36e0a6/cancers-14-03058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/8edf9d2e4b05/cancers-14-03058-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/8e2e78cd7263/cancers-14-03058-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/74c4543427bd/cancers-14-03058-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/1131c610784f/cancers-14-03058-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/a7fd13f060df/cancers-14-03058-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/69b4c00212b3/cancers-14-03058-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/2bc690d2ce58/cancers-14-03058-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/1d356a36e0a6/cancers-14-03058-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/8edf9d2e4b05/cancers-14-03058-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/8e2e78cd7263/cancers-14-03058-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/74c4543427bd/cancers-14-03058-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/1131c610784f/cancers-14-03058-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/a7fd13f060df/cancers-14-03058-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ddfc/9264868/69b4c00212b3/cancers-14-03058-g008.jpg

相似文献

1
Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations.前列腺癌幸存者存在长期的、残留的全身免疫改变。
Cancers (Basel). 2022 Jun 22;14(13):3058. doi: 10.3390/cancers14133058.
2
Autologous Immune Enhancement Therapy for Cancer - Our experience since 2004.癌症自体免疫增强疗法——我们自2004年以来的经验
J Stem Cells Regen Med. 2012 Nov 26;8(3):205-6. eCollection 2012.
3
T- and NK-cell populations with regulatory phenotype and markers of apoptosis in circulating lymphocytes of patients with CIN3 or microcarcinoma of the cervix: evidence for potential mechanisms of immune suppression.CIN3或宫颈微癌患者循环淋巴细胞中具有调节表型和凋亡标志物的T细胞和NK细胞群体:免疫抑制潜在机制的证据
Infect Agent Cancer. 2017 Oct 17;12:56. doi: 10.1186/s13027-017-0166-1. eCollection 2017.
4
Monitoring Pre- and Post-Operative Immune Alterations in Patients With Locoregional Colorectal Cancer Who Underwent Laparoscopy by Single-Cell Mass Cytometry.应用单细胞质谱流式细胞术监测腹腔镜局部结直肠癌患者术前和术后的免疫变化。
Front Immunol. 2022 Feb 3;13:807539. doi: 10.3389/fimmu.2022.807539. eCollection 2022.
5
Radiotherapy-Induced Changes in the Systemic Immune and Inflammation Parameters of Head and Neck Cancer Patients.放疗引起的头颈癌患者全身免疫和炎症参数变化
Cancers (Basel). 2019 Sep 6;11(9):1324. doi: 10.3390/cancers11091324.
6
Early effects of different brain radiotherapy modalities on circulating leucocyte subpopulations in rodents.不同脑放射治疗模式对啮齿动物循环白细胞亚群的早期影响。
Int J Radiat Biol. 2024;100(5):744-755. doi: 10.1080/09553002.2024.2324471. Epub 2024 Mar 11.
7
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.结直肠癌相关的免疫耗竭涉及 T 和 B 淋巴细胞以及常规 NK 细胞,与总生存期更短相关。
Front Immunol. 2021 Dec 16;12:778329. doi: 10.3389/fimmu.2021.778329. eCollection 2021.
8
Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.6至12个月时前列腺特异性抗原检测不到:前列腺近距离放射治疗后接受激素治疗患者早期治疗成功的新标志物。
Cancer. 2005 Jun 15;103(12):2499-506. doi: 10.1002/cncr.21077.
9
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.阿仑单抗治疗可改变多发性硬化症患者循环中的固有免疫细胞。
Neurol Neuroimmunol Neuroinflamm. 2016 Oct 12;3(6):e289. doi: 10.1212/NXI.0000000000000289. eCollection 2016 Dec.
10
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.工程化单核细胞衍生的树突状细胞以分泌干扰素-α可增强其促进适应性和先天性抗肿瘤免疫效应功能的能力。
Cancer Immunol Immunother. 2015 Jul;64(7):831-42. doi: 10.1007/s00262-015-1688-2. Epub 2015 Apr 12.

引用本文的文献

1
Methylation-based immune deconvolution in prostate cancer patients before and after radical prostatectomy.前列腺癌患者根治性前列腺切除术前和术后基于甲基化的免疫反卷积分析
Cancer Causes Control. 2025 Feb;36(2):101-106. doi: 10.1007/s10552-024-01924-x. Epub 2024 Oct 10.

本文引用的文献

1
Human CD3CD56NKT-like cells express a range of complement receptors and C3 activation has negative effects on these cell activity and effector function.人 CD3CD56NKT 样细胞表达一系列补体受体,C3 激活对这些细胞的活性和效应功能有负面影响。
Hum Immunol. 2021 Sep;82(9):625-633. doi: 10.1016/j.humimm.2021.06.001. Epub 2021 Jun 13.
2
Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients.前列腺癌患者诊断、预后及治疗反应的血液源性生物标志物
J Pers Med. 2021 Apr 13;11(4):296. doi: 10.3390/jpm11040296.
3
Low-grade chronic inflammation and immune alterations in childhood and adolescent cancer survivors: A contribution to accelerated aging?
儿童和青少年癌症幸存者中的低度慢性炎症和免疫改变:加速衰老的一个贡献?
Cancer Med. 2021 Mar;10(5):1772-1782. doi: 10.1002/cam4.3788. Epub 2021 Feb 19.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological Distress.睾丸癌幸存者的免疫衰老:癌症治疗和心理困扰的潜在影响
Front Oncol. 2021 Jan 15;10:564346. doi: 10.3389/fonc.2020.564346. eCollection 2020.
6
The role of regulatory T cells in the pathogenesis and treatment of prostate cancer.调节性 T 细胞在前列腺癌发病机制和治疗中的作用。
Life Sci. 2021 Nov 1;284:119132. doi: 10.1016/j.lfs.2021.119132. Epub 2021 Jan 26.
7
Low dose ionizing radiation effects on the immune system.低剂量电离辐射对免疫系统的影响。
Environ Int. 2021 Apr;149:106212. doi: 10.1016/j.envint.2020.106212. Epub 2020 Dec 5.
8
Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer.立体定向体部放射治疗与低剂量率近距离放射治疗低危和中危前列腺癌的生化控制和毒性结果。
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1232-1242. doi: 10.1016/j.ijrobp.2020.11.003. Epub 2020 Nov 7.
9
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance.PD-1 抑制调节性 T 细胞的抑制活性对于免疫耐受至关重要。
J Exp Med. 2021 Jan 4;218(1). doi: 10.1084/jem.20182232.
10
Radiotherapy-Induced High Neutrophil-to-Lymphocyte Ratio is a Negative Prognostic Factor in Patients with Breast Cancer.放疗诱导的高中性粒细胞与淋巴细胞比值是乳腺癌患者的不良预后因素。
Cancers (Basel). 2020 Jul 14;12(7):1896. doi: 10.3390/cancers12071896.